Ana Espinosa
Chief Operating Officer
Miramoon Pharma
San Sebastian, Spain
12 profile visits
PhD neuroscientist with 20+ years across academia and industry. Since 2020, focused on translating science into value by supporting drug development, leading cross-functional teams, and advancing innovative therapies with strong patient and market impact.
My organisation
Miramoon Pharma is a spin-off of the University of the Basque Country and the Biogipuzkoa Health Research Institute, developing first-in-class small molecules for complex diseases. Leveraging a proprietary chemistry platform, we target ophthalmology, muscle disorders, and CNS diseases. Our approach aims to slow disease progression, extend the therapeutic window, and unlock significant value for patients and investors.